On Apr. 21, 2020, University of Oxford announced that it had successfully obtained re-registration of the T-SPOT.TB test in China. The re-registration was granted by the Chinese National Medical Products Administration (NMPA) on Apr. 13, 2020 and lasts until Apr. 12, 2025.

Since first receiving approval in 2010, and its first re-registration in 2014, the T-SPOT.TB test has been rapidly adopted in China and more than 6 million T-SPOT.TB tests have been administered in the country since 2010.